Press releases

Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio

Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit

Disclosure of transparency notification

Agreement regarding recapitalization of operating subsidiaries by secured creditors and wind down of listed holding company

Biocartis announces H1 2023 Results and provides an update on the operational reorganization an recapitalization

Biocartis 2023 Half-Year Results Webcast on 26 September 2023

Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders

Biocartis Announces 2023 Half-Year Results on 26 September 2023

Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ Platform

Biocartis appoints George Cardoza as new CFO and Head of Service Delivery